How to Fight a Hearing Aid, Cochlear Implant, or BAHA Denial

Insurance denials for hearing care are common, but they are not always correct. This guide covers conventional hearing aids, cochlear implants (CI), bone-anchored hearing aids (BAHA, Osia, Ponto), auditory brainstem implants (ABI), and related audiology services. Denials happen frequently because federal Medicare law explicitly excludes hearing aids—but that exclusion does not apply to Medicare Advantage supplemental benefits, Medicaid EPSDT for children, state mandates (22+ states require pediatric or adult hearing aid coverage), or devices classified as prosthetics rather than hearing aids (cochlear implants and bone-anchored devices). Insurers often apply blanket "hearing aid" denials without distinguishing between a $2,000 behind-the-ear device and a $50,000 cochlear implant surgery, or without recognizing your state's coverage mandate. Understanding which legal framework applies to your situation—and citing the right statute, guideline, or trial—can turn a "no" into a "yes."

---

Why Insurers Deny Hearing Aids, Cochlear Implants, and BAHA

1. "Hearing aids are not a covered benefit"

This is the most common blanket denial. Insurers cite 42 CFR §411.15(d) or the Social Security Act §1862(a)(7), which excludes "hearing aids or examinations therefor" from traditional Medicare Part B. The problem: this exclusion does not apply to Medicare Advantage plans (which offer supplemental hearing benefits in ~96% of plans as of 2024), Medicaid (especially for children under EPSDT), employer-sponsored commercial plans, or devices that are not hearing aids—such as cochlear implants and bone-anchored devices, which are classified as prosthetic devices under §1861(s)(8).

2. "You do not meet medical necessity criteria for cochlear implant"

Insurers deny cochlear implants by claiming the patient has "too much" residual hearing or has not tried hearing aids long enough. Many denials cite outdated criteria (e.g., ≤40% sentence recognition), ignoring that CMS National Coverage Determination 50.3 was expanded on September 26, 2022 to cover patients with ≤60% sentence recognition in the best-aided listening condition. Denials also ignore the requirement for a 3–6 month hearing aid trial (which many patients have completed) or fail to recognize bilateral cochlear implant candidacy.

3. "Benefit cap exceeded" or "hearing aid allowance exhausted"

Medicare Advantage and many commercial plans impose annual or per-device dollar caps (e.g., $1,500 every three years). Insurers deny claims once the cap is reached, even when additional hearing aids are medically necessary due to loss, damage, or a child's growth. This denial ignores tier exceptions, replacement provisions in state mandates, and medical-necessity overrides for patients with documented vocational, educational, or cognitive impacts.

4. "Bone-anchored device is considered a hearing aid—not covered"

BAHA, Osia, and Ponto denials often misclassify these surgically implanted osseointegrated devices as "hearing aids." This is incorrect. CMS and the FDA classify bone-anchored devices as prosthetic devices under Social Security Act §1861(s)(8) and Medicare Benefit Policy Manual Chapter 15 §120. Traditional Medicare and Medicare Advantage must cover prosthetic devices; the hearing aid exclusion does not apply.

5. "No state mandate or EPSDT does not apply"

For pediatric patients, insurers deny hearing aids by claiming no state law requires coverage or by asserting the child does not qualify for Medicaid's Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit (42 USC §1396d(r)(5)). In fact, 22+ states have pediatric hearing aid mandates, and EPSDT requires Medicaid to cover any medically necessary service for a child under 21, including hearing aids, even if the state Medicaid plan does not ordinarily cover them. Insurers also deny adult hearing aid claims in states with adult mandates (e.g., Illinois, New Hampshire, Rhode Island).

---

The Citations Insurers Respect

When you appeal, reference these specific laws, guidelines, and evidence by name and year. Do not paraphrase; use the exact title.

Federal statutes and regulations

• 42 CFR §411.15(d) and Social Security Act §1862(a)(7): Medicare statutory exclusion for "hearing aids or examinations therefor." Applies only to traditional Medicare Part B—does not prohibit Medicare Advantage supplemental benefits or coverage of prosthetic devices.
• Social Security Act §1861(s)(8): Defines prosthetic devices (includes cochlear implants and bone-anchored devices).
• 42 USC §1396d(r)(5): Medicaid EPSDT benefit—requires coverage of any medically necessary service for children under 21.
• CMS National Coverage Determination (NCD) 50.3 (Cochlear Implantation), revised effective September 26, 2022: Covers bilateral pre- or post-lingual severe-to-profound sensorineural hearing loss with ≤60% sentence recognition in best-aided listening condition. Includes bilateral cochlear implants.
• Medicare Benefit Policy Manual Chapter 15 §120: Clarifies coverage of auditory osseointegrated devices (BAHA, Osia, Ponto) as prosthetic devices, not hearing aids.
• CMS Medicare Managed Care Manual Chapter 4 and CHRONIC Care Act (2020): Authorizes Medicare Advantage plans to offer supplemental hearing benefits; ~96% of MA plans do so as of 2024.

State mandates

• 22+ states with pediatric hearing aid mandates: Including Illinois (215 ILCS 5/356z.10), Arkansas, Colorado, Connecticut, Delaware, Louisiana, Maryland, Massachusetts, Missouri, New Hampshire, New Jersey, New Mexico, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas, and others. Most require coverage for children under 18 or 21, with replacement every 3–5 years.
• Adult hearing aid mandates: Illinois (215 ILCS 5/356z.10 also covers adults), New Hampshire (RSA 415:6-g and RSA 420-A:7-e), Rhode Island (RI Gen. Laws §27-20-64).

Clinical guidelines

• Joint Committee on Infant Hearing (JCIH) 1-3-6 benchmarks (Pediatrics 2019, reaffirmed 2023): Screen by 1 month, diagnose by 3 months, intervene by 6 months—supports early pediatric hearing aid fitting.
• American Academy of Audiology Clinical Practice Guidelines: Pediatric Amplification (2013, updated 2020): Evidence-based criteria for fitting hearing aids in children.
• FDA Over-the-Counter (OTC) Hearing Aid Rule (October 2022): Establishes OTC category for adults ≥18 with perceived mild-to-moderate hearing loss; does not eliminate medical necessity for custom or prescription devices.
• Lancet Commission on Dementia Prevention, Intervention, and Care (2020, updated 2024): Identifies midlife hearing loss as the largest modifiable risk factor for dementia—supports medical necessity arguments for hearing aids in adults at cognitive risk.
• Consensus statement on bilateral cochlear implantation (multiple sources including Ear and Hearing 2016, International Journal of Audiology 2020): Documents binaural hearing benefits (localization, speech in noise).

Key trial evidence (for cochlear implants)

• CMS coverage decision (2022) expanding NCD 50.3 to ≤60% sentence recognition cites systematic review of FDA premarket approval data and real-world outcomes.
• Bilateral CI outcomes literature: AzBio sentence test, Hearing in Noise Test (HINT), and quality-of-life measures support bilateral over unilateral implantation.

---

How to Argue Against Each Denial Reason

Denial: "Hearing aids are not a covered benefit"

If you have Medicare Advantage:

1. Obtain your Evidence of Coverage (EOC) document and look for the "Hearing Services" or "Supplemental Benefits" section. ~96% of MA plans cover hearing aids with an annual allowance.

2. In your appeal, write: "This denial incorrectly applies the traditional Medicare Part B exclusion (42 CFR §411.15(d)) to a Medicare Advantage plan. CMS Medicare Managed Care Manual Chapter 4 authorizes MA plans to offer supplemental hearing benefits. My plan's [year] Evidence of Coverage, page [X], states [quote the coverage language]. I am within the annual allowance and meet medical necessity criteria."

3. Attach the EOC excerpt and your audiogram showing the degree of hearing loss.

If you have Medicaid and the patient is under 21:

1. In your appeal, write: "Federal law requires Medicaid to cover hearing aids for children under 21 through the EPSDT benefit (42 USC §1396d(r)(5)). EPSDT mandates coverage of any medically necessary service to correct or ameliorate a defect, even if the state Medicaid plan does not ordinarily cover it. The Joint Committee on Infant Hearing 1-3-6 guidelines (Pediatrics 2019) establish the standard of care for early intervention."

2. Attach a letter from the audiologist documenting the child's hearing loss, speech-language delay risk, and educational impact.

3. If the child has an Individualized Education Program (IEP) or 504 plan, attach it to demonstrate educational necessity.

If your state has a hearing aid mandate:

1. Look up your state's statute (see list above). In Illinois, for example, cite "215 ILCS 5/356z.10 requires coverage of hearing aids for pediatric and adult patients, with replacement every 48 months. This is a state-mandated benefit; the plan must comply."

2. Confirm your plan is fully insured (subject to state law) and not self-funded ERISA (which preempts state mandates). Ask your HR department or look for the plan administrator's name on your insurance card—if it is a third-party administrator (TPA), the plan may be self-funded and exempt. If fully insured, state law applies.

3. In your appeal, write: "This plan is subject to [state] law. [Cite statute]. The denial violates state mandate. I request immediate reversal and coverage per statute."

If the denied device is a BAHA, Osia, Ponto, or cochlear implant:

1. Write: "This denial misclassifies a surgically implanted prosthetic device as a 'hearing aid.' Cochlear implants and bone-anchored auditory devices are prosthetic devices under Social Security Act §1861(s)(8) and Medicare Benefit Policy Manual Chapter 15 §120. The Medicare hearing aid exclusion (42 CFR §411.15(d)) does not apply to prosthetic devices. Federal law requires coverage."

2. Attach your surgeon's letter explaining the device is osseointegrated (for BAHA/Osia/Ponto) or a cochlear implant electrode array, not an air-conduction hearing aid.

---

Denial: "You do not meet medical necessity criteria for cochlear implant"

If your sentence recognition is ≤60% best-aided:

1. Obtain your most recent audiologic evaluation with AzBio sentence scores or equivalent recorded in the best-aided listening condition (wearing optimally fitted hearing aids in quiet or in the ear that performs best). The test must be administered by a qualified audiologist within the past 6 months.

2. Write: "CMS National Coverage Determination 50.3, revised effective September 26, 2022, covers cochlear implantation for patients with ≤60% sentence recognition in the best-aided listening condition. My AzBio score is [X]% [date]. I meet the expanded CMS criteria."

3. If the denial cites the old 40% threshold, write: "The denial applies an outdated threshold. CMS expanded NCD 50.3 in September 2022. The current threshold is ≤60%, which I meet."

If the insurer says you have not tried hearing aids long enough:

1. Document your hearing aid trial: dates of fitting, make/model, follow-up visits, and functional outcome. A 3–6 month trial is standard; 6 months is often sufficient.

2. Write: "I completed a [duration] trial with [device] from [start date] to [end date]. Despite optimal fitting and regular follow-up, my best-aided sentence recognition plateaued at [X]%, demonstrating limited benefit from amplification per NCD 50.3."

3. Attach your audiologist's report documenting the trial and recommendation for cochlear implant evaluation.

If you are seeking bilateral cochlear implants:

1. Cite the 2022 NCD 50.3 revision, which explicitly states "one or two cochlear implants" may be covered.

2. Write: "CMS NCD 50.3 (2022) covers bilateral cochlear implantation. Peer-reviewed evidence (Ear and Hearing 2016; International Journal of Audiology 2020) demonstrates binaural hearing improves sound localization, speech understanding in noise, and quality of life. My audiologist recommends bilateral implants for [reason: bilateral severe-profound loss, single-sided deafness inadequately managed with CROS, etc.]."

3. Attach a letter from your surgeon or audiologist explaining why bilateral is medically necessary in your case.

---

Denial: "Benefit cap exceeded" or "hearing aid allowance exhausted"

Request a tier exception or formulary exception:

1. Medicare Advantage and many commercial plans allow exceptions to dollar caps when a service is medically necessary and no lower-cost alternative is appropriate.

2. Write: "I request a formulary/tier exception under [plan name] policy. My hearing loss [describe: progressive, vocational impact, cognitive risk per Lancet 2020/2024] requires continued amplification beyond the standard allowance. [Doctor name], my audiologist, certifies no lower-cost device is medically appropriate [attach letter]."

3. Document functional impact: job loss or performance warnings, educational failure (for children), social isolation, depression, or cognitive decline risk.

If the patient is a child and a state mandate applies:

1. Many state mandates include replacement provisions (e.g., every 3–5 years, or when medically necessary due to growth, loss, or damage).

2. Write: "[State statute] requires replacement hearing aids when medically necessary. My child has outgrown the current devices [or lost/damaged them]. Audiologist [name] certifies new devices are medically necessary [attach letter]."

If the device is a cochlear implant processor upgrade:

1. Write: "A cochlear implant sound processor is not a 'hearing aid'; it is a component of a prosthetic device covered under §1861(s)(8). The denial of a medically necessary processor upgrade [e.g., due to failure, obsolescence, improved speech understanding with newer technology] is inconsistent with coverage of the original implant."

---

Denial: "Bone-anchored device is considered a hearing aid—not covered"

1. Write: "BAHA, Osia, and Ponto are osseointegrated prosthetic devices, not hearing aids. They are surgically implanted and function via bone conduction through a titanium abutment or magnetic coupling. Social Security Act §1861(s)(8) and Medicare Benefit Policy Manual Chapter 15 §120 classify these devices as prosthetics. The Medicare hearing aid exclusion (42 CFR §411.15(d)) does not apply."

2. Attach your surgeon's letter explaining:

- The medical indication (conductive or mixed hearing loss, single-sided deafness, chronic ear disease contraindicating conventional hearing aids).

- The surgical procedure code (e.g., CPT 69710 or 69714 for BAHA implantation).

- Why a conventional hearing aid is not appropriate (e.g., atresia, canal stenosis, chronic otorrhea).

3. Cite the FDA device classification: BAHA and similar devices are Class II or III medical devices, not over-the-counter consumer products.

---

Denial: "No state mandate" or "EPSDT does not apply"

If the patient is a child on Medicaid:

1. Write: "EPSDT (42 USC §1396d(r)(5)) requires Medicaid coverage of 'all medically necessary services' for children under 21, including hearing aids, even if the state Medicaid plan does not ordinarily cover them. The Joint Committee on Infant Hearing (Pediatrics 2019) and American Academy of Audiology Pediatric Amplification Guidelines (2020) establish the standard of care. Denial of hearing aids for a child with documented hearing loss violates federal EPSDT requirements."

2. If the child attends school, attach the IEP or 504 plan and a letter from the school audiologist or special education coordinator documenting the need for amplification to access the curriculum.

If you live in a state with a mandate and your plan is fully insured:

1. Verify your state is on the mandate list and your plan is not self-funded ERISA (check with HR or your insurer).

2. Write: "[State statute, e.g., 215 ILCS 5/356z.10] mandates coverage of hearing aids for [children/adults]. This plan, issued in [state], must comply with state law. I meet the statute's criteria [age, audiometric thresholds, etc.]. The denial is unlawful."

3. If the insurer is domiciled in another state, confirm your plan is sold and regulated in your state of residence—state mandates apply to the state where the policy is issued and regulated, typically where you live.

---

What We Do

We help patients draft physician-ready, citation-grade appeal letters in minutes. You answer a few questions about your audiogram, prior hearing aid trial, and denial reason; our system generates a letter that cites the correct statute, guideline, and evidence—ready for your audiologist or ENT to review, sign, and submit. We do not provide legal or medical advice, and we are not a law firm. We provide templates and tools to make it easier for you and your provider to fight back.

---

Sources

1. 42 CFR §411.15(d) – Medicare statutory exclusion for hearing aids.

2. Social Security Act §1862(a)(7) – Medicare hearing aid exclusion (codified at 42 CFR §411.15(d)).

3. Social Security Act §1861(s)(8) – Definition of prosthetic devices.

4. 42 USC §1396d(r)(5) – Medicaid EPSDT benefit.

5. CMS National Coverage Determination (NCD) 50.3 (Cochlear Implantation), revised effective September 26, 2022.

6. CMS Medicare Benefit Policy Manual, Chapter 15, §120 – Coverage of auditory osseointegrated devices.

7. CMS Medicare Managed Care Manual, Chapter 4 – Medicare Advantage supplemental benefits authority.

8. CHRONIC Care Act (2020) – Expansion of Medicare Advantage supplemental benefits.

9. Joint Committee on Infant Hearing (JCIH), "Year 2019 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs," Pediatrics 2019; reaffirmed 2023.

10. American Academy of Audiology, "Clinical Practice Guidelines: Pediatric Amplification" (2013, updated 2020).

11. FDA, "Establishing Over-the-Counter Hearing Aids," Final Rule, Federal Register, October 17, 2022.

12. Lancet Commission on Dementia Prevention, Intervention, and Care (2020, updated 2024) – Hearing loss as a modifiable dementia risk factor.

13. State hearing aid mandates – Illinois (215 ILCS 5/356z.10); New Hampshire (RSA 415:6-g, RSA 420-A:7-e); Rhode Island (RI Gen. Laws §27-20-64); and statutes in 19+ other states (consult the National Conference of State Legislatures or your state insurance department).

14. Consensus statement on bilateral cochlear implantation, Ear and Hearing 2016; International Journal of Audiology 2020 – Binaural hearing benefits.

---

Disclaimer: This guide is for educational purposes. It is not legal or medical advice. Consult your audiologist, ENT, or attorney for guidance specific to your case. Appeal deadlines are strict—typically 60–180 days from the date of denial. Do not delay.